关注
Vera Frajzyngier
Vera Frajzyngier
在 pfizer.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility
A Neaigus, VA Gyarmathy, M Miller, VM Frajzyngier, SR Friedman, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (4), 493-503, 2006
1922006
Gender differences in injection risk behaviors at the first injection episode
V Frajzyngier, A Neaigus, VA Gyarmathy, M Miller, SR Friedman
Drug and Alcohol Dependence 89 (2-3), 145-152, 2007
1482007
Factors affecting vasectomy acceptability in Tanzania
A Bunce, G Guest, H Searing, V Frajzyngier, P Riwa, J Kanama, I Achwal
International family planning perspectives, 13-21, 2007
1232007
Determinants of postoperative outcomes of female genital fistula repair surgery
MA Barone, V Frajzyngier, J Ruminjo, F Asiimwe, TH Barry, A Bello, ...
Obstetrics and gynecology 120 (3), 524, 2012
912012
Factors influencing urinary fistula repair outcomes in developing countries: a systematic review
V Frajzyngier, J Ruminjo, MA Barone
American journal of obstetrics and gynecology 207 (4), 248-258, 2012
812012
Profiles and experiences of women undergoing genital fistula repair: findings from five countries
E Landry, V Frajzyngier, J Ruminjo, F Asiimwe, TH Barry, A Bello, ...
Global public health 8 (8), 926-942, 2013
762013
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors
A Neaigus, VA Gyarmathy, M Miller, V Frajzyngier, M Zhao, SR Friedman, ...
Drug and alcohol dependence 89 (2-3), 234-243, 2007
662007
Breakdown of simple female genital fistula repair after 7 day versus 14 day postoperative bladder catheterisation: a randomised, controlled, open-label, non-inferiority trial
MA Barone, M Widmer, S Arrowsmith, J Ruminjo, A Seuc, E Landry, ...
The Lancet 386 (9988), 56-62, 2015
622015
Patient impact and economic burden of mild-to-moderate atopic dermatitis
AA Hebert, G Stingl, LAK Ho, C Lynde, JC Cappelleri, AM Tallman, ...
Current medical research and opinion 34 (12), 2177-2185, 2018
542018
Factors influencing choice of surgical route of repair of genitourinary fistula, and the influence of route of repair on surgical outcomes: findings from a prospective cohort study
V Frajzyngier, J Ruminjo, F Asiimwe, TH Barry, A Bello, D Danladi, ...
BJOG: An International Journal of Obstetrics & Gynaecology 119 (11), 1344-1353, 2012
542012
Safety of adult medical male circumcision performed by non-physician clinicians in Kenya: a prospective cohort study
V Frajzyngier, G Odingo, M Barone, P Perchal, M Pavin
Global Health: Science and Practice 2 (1), 93-102, 2014
442014
Development and comparison of prognostic scoring systems for surgical closure of genitourinary fistula
V Frajzyngier, G Li, E Larson, J Ruminjo, MA Barone
American journal of obstetrics and gynecology 208 (2), 112. e1-112. e11, 2013
342013
Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials
BE Strober, AB Gottlieb, PCM van de Kerkhof, L Puig, H Bachelez, ...
British Journal of Dermatology 180 (1), 67-75, 2019
332019
Clinical procedures and practices used in the perioperative treatment of female genital fistula during a prospective cohort study
JK Ruminjo, V Frajzyngier, M Bashir Abdullahi, F Asiimwe, ...
BMC pregnancy and childbirth 14, 1-13, 2014
262014
Non-inferiority of short-term urethral catheterization following fistula repair surgery: study protocol for a randomized controlled trial
MA Barone, V Frajzyngier, S Arrowsmith, J Ruminjo, A Seuc, E Landry, ...
BMC Women's Health 12, 1-7, 2012
182012
An evaluation of the effectiveness of risk minimization measures for tigecycline in the European Union
V Frajzyngier, A Quintana, H Tucker, M Wible, A Hickman, N Baillon-Plot, ...
Pharmaceutical Medicine 31, 89-99, 2017
42017
I027 DETERMINANTS OF FISTULA REPAIR POST‐OPERATIVE OUTCOMES: A PROSPECTIVE COHORT STUDY
M Barone, V Frajzyngier, J Ruminjo, F Asiimwe, TH Barry, A Bello, ...
International Journal of Gynecology & Obstetrics 119, S167-S167, 2012
32012
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study
SR Hoffman, S Governor, K Daniels, RM Seals, NJ Ziyadeh, FT Wang, ...
Menopause (New York, NY) 30 (8), 824, 2023
22023
Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib
G Dasic, T Jones, V Frajzyngier, R Rojo, A Madsen, H Valdez
Pharmacology research & perspectives 6 (1), e00371, 2018
22018
Obstetric and neonatal outcomes in South Africa
CL Cutland, S Sawry, L Fairlie, S Barnabas, V Frajzyngier, J Le Roux, ...
Vaccine, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20